SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 47 850 KRW -1.34% Market Closed
Market Cap: 3.7T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note
SK Bioscience Co Ltd
/
Balance Sheet
/
Cash Equivalents

SK Bioscience Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SK Bioscience Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
SK Bioscience Co Ltd
KRX:302440
Cash Equivalents
₩127B
CAGR 3-Years
72%
CAGR 5-Years
95%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash Equivalents
-₩440
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Cash Equivalents
₩12.3B
CAGR 3-Years
-59%
CAGR 5-Years
-34%
CAGR 10-Years
-4%
H
Hugel Inc
KOSDAQ:145020
Cash Equivalents
₩182.9B
CAGR 3-Years
61%
CAGR 5-Years
4%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash Equivalents
₩2B
CAGR 3-Years
-56%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash Equivalents
₩37.8B
CAGR 3-Years
48%
CAGR 5-Years
45%
CAGR 10-Years
N/A
No Stocks Found

SK Bioscience Co Ltd
Glance View

Market Cap
3.7T KRW
Industry
Biotechnology

SK bioscience Co., Ltd. engages in the development and distribution of bio and vaccine products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-03-18. The firm's main products include vaccines such as SKYCellflu and Rotatech. The firm also sells infusion solutions. In addition, the Company engages in technology export business. The firm sells its products in domestic and overseas markets.

Intrinsic Value
35 489.69 KRW
Overvaluation 26%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is SK Bioscience Co Ltd's Cash Equivalents?
Cash Equivalents
127B KRW

Based on the financial report for Dec 31, 2023, SK Bioscience Co Ltd's Cash Equivalents amounts to 127B KRW.

What is SK Bioscience Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
95%

Over the last year, the Cash Equivalents growth was -44%. The average annual Cash Equivalents growth rates for SK Bioscience Co Ltd have been 72% over the past three years , 95% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.